Search Results - "de Lucas, M.D. García"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea–hypopnoea syndrome

    Liraglutide treatment in a patient with HIV, type 2 diabetes and sleep apnoea–hypopnoea syndrome by García de Lucas, M.D, Olalla Sierra, J, Piña Fernández, J

    Published in Diabetes & metabolism (01-02-2015)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Canagliflozin as a replacement therapy for patients with type 2 diabetes not responding to GLP-1 receptor agonists

    Canagliflozin as a replacement therapy for patients with type 2 diabetes not responding to GLP-1 receptor agonists by Garcia de Lucas, M.D, Olalla Sierra, J

    Published in Diabetes & metabolism (01-09-2017)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    IDF23-0145 Once-weekly semaglutide in type 2 diabetes patients with heart failure with reduced left ventricular ejection fraction

    IDF23-0145 Once-weekly semaglutide in type 2 diabetes patients with heart failure with reduced left ventricular ejection fraction by Calero, A. Trenas, Pérez-Velasco, M.A., Sanz-Cánovas, J., Ricci, M., López-Sampalo, A., López-Carmona, M.D., Cobos-Palacios, L., Bernal-López, M.R., de Lucas, M.D. García, Jansen-Chaparro, S., Gómez-Huelgas, R., Pérez-Belmonte, L.M.

    Published in Diabetes research and clinical practice (01-03-2024)
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Epidemiologic study of primary systemic vasculitides in adults in Southeastern Spain (Costa del Sol Occidental region, Málaga)

    Epidemiologic study of primary systemic vasculitides in adults in Southeastern Spain (Costa del Sol Occidental region, Málaga) by Romero-Gómez, C., Aguilar-García, J.A., García De Lucas, M.D., Cotos-Canca, R., García-Alegría, J.J., Hernández-Rodríguez, J.

    Published in La Presse médicale (1983) (01-04-2013)
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Efficacy and safety of replacing sitagliptin with canagliflozin in real-world patients with type 2 diabetes uncontrolled with sitagliptin combined with metformin and/or gliclazide: The SITA-CANA Switch Study

    Efficacy and safety of replacing sitagliptin with canagliflozin in real-world patients with type 2 diabetes uncontrolled with sitagliptin combined with metformin and/or gliclazide: The SITA-CANA Switch Study by Garcia de Lucas, M.D., Pérez Belmonte, L.M., Suárez Tembra, M., Olalla Sierra, J., Gómez Huelgas, R.

    Published in Diabetes & metabolism (01-09-2018)
    “…To analyze the efficacy and safety of replacing sitagliptin with canagliflozin in patients with type 2 diabetes (T2D) and poor metabolic control despite…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: